Geron (GERN) Share-based Compensation (2010 - 2026)

Geron's (GERN) quarterly Share-based Compensation came in at $4.9 million in Q1 2026, down 33.81% year-on-year from $7.4 million in Q1 2025, and up 123.62% quarter-over-quarter from -$20.8 million in Q4 2025.

Geron (GERN) Share-based Compensation (2010 - 2026) Analysis & Trends

Geron has disclosed Share-based Compensation across 17 years of filings, most recently posting $4.9 million for Q1 2026.

  • Share-based Compensation for Q1 2026 came in at $4.9 million, down 33.81% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.4 million (down 108.99% YoY), and the FY2025 annual result was $88000.0, down 34.81% from the prior year.
  • Share-based Compensation came in at $4.9 million for Q1 2026 at Geron, up from -$20.8 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $20.8 million in Q3 2025 to a low of -$20.8 million in Q4 2025.
  • The 5-year median for Share-based Compensation is $3.0 million (2023), against an average of $2.6 million.
  • Across the five-year window, Share-based Compensation jumped 249.2% in 2023 and tumbled 160100.0% in 2025, its largest moves.
  • Geron's Share-based Compensation stood at -$5.5 million in 2022, then jumped by 103.21% to $178000.0 in 2023, then sank by 92.7% to $13000.0 in 2024, then sank by 160100.0% to -$20.8 million in 2025, then soared by 123.62% to $4.9 million in 2026.
  • The last three Share-based Compensation figures came in at $4.9 million (Q1 2026), -$20.8 million (Q4 2025), and $20.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 305,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.71 Bn 91.71 Bn - 26.47 Mn
10 Geron 729,618.77 729,618.77 - 4.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.91 Mn
Mar 31, 2026 4.91 Mn
Dec 31, 2025 -20.80 Mn
Dec 31, 2025 -20.80 Mn
Sep 30, 2025 20.85 Mn
Sep 30, 2025 20.85 Mn
Jun 30, 2025 -7.38 Mn
Jun 30, 2025 -7.38 Mn
Mar 31, 2025 7.42 Mn
Mar 31, 2025 7.42 Mn
Dec 31, 2024 13,000.00
Dec 31, 2024 13,000.00
Sep 30, 2024 6.89 Mn
Sep 30, 2024 6.89 Mn
Jun 30, 2024 12.63 Mn
Jun 30, 2024 12.63 Mn
Mar 31, 2024 4.88 Mn
Mar 31, 2024 4.88 Mn
Dec 31, 2023 178,000.00
Dec 31, 2023 178,000.00